HGF mimetic

This page covers all HGF mimetic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting MET receptor.

Targets

MET receptor

Phase 3 pipeline (1)

• ANG-3777 · Angion Biomedica Corp · Cardiovascular
  ANG-3777 is a hepatocyte growth factor (HGF) mimetic that activates the MET receptor to promote tissue repair and regeneration.

Patent intelligence

• hgf mimetic patent landscape — aggregated cliff calendar, attackable patents, originator estates